Theo Heller

2002–2025 年に発表

119
論文数
20,064
被引用数
62
h 指数
112
i10 指数

被引用数

Theo Heller の年別被引用数1993 年: 被引用 1 件1994 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 2 件2003 年: 被引用 8 件2004 年: 被引用 27 件2005 年: 被引用 60 件2006 年: 被引用 86 件2007 年: 被引用 82 件2008 年: 被引用 104 件2009 年: 被引用 100 件2010 年: 被引用 95 件2011 年: 被引用 98 件2012 年: 被引用 109 件2013 年: 被引用 106 件2014 年: 被引用 122 件2015 年: 被引用 148 件2016 年: 被引用 169 件2017 年: 被引用 180 件2018 年: 被引用 177 件2019 年: 被引用 717 件2020 年: 被引用 812 件2021 年: 被引用 798 件2022 年: 被引用 508 件2023 年: 被引用 440 件2024 年: 被引用 700 件2025 年: 被引用 271 件2026 年: 被引用 2 件1995〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,544 件、この内訳の 25.7%中国: 引用元論文 666 件、この内訳の 6.7%ドイツ: 引用元論文 643 件、この内訳の 6.5%イタリア: 引用元論文 609 件、この内訳の 6.2%イギリス: 引用元論文 602 件、この内訳の 6.1%フランス: 引用元論文 579 件、この内訳の 5.8%スペイン: 引用元論文 333 件、この内訳の 3.4%カナダ: 引用元論文 318 件、この内訳の 3.2%日本: 引用元論文 273 件、この内訳の 2.8%オーストラリア: 引用元論文 243 件、この内訳の 2.5%スイス: 引用元論文 242 件、この内訳の 2.4%オランダ: 引用元論文 235 件、この内訳の 2.4%
0%25.7%その他 26.3%

分野

  • Medicine69.5%
  • Immunology and Microbiology16.9%
  • Biochemistry, Genetics and Molecular Biology12.1%
  • Neuroscience0.4%
  • Engineering0.2%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • その他0.7%

トピック

  • Hematopoietic Stem Cell Transplantation6.5%
  • Liver Disease Diagnosis and Treatment5.3%
  • Hepatitis C virus research4.3%
  • Immune Cell Function and Interaction3.3%
  • Hepatitis B Virus Studies3.1%
  • Immunodeficiency and Autoimmune Disorders2.6%
  • その他74.9%

共著者

全論文

検索で開く
  1. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2014 被引用: 5,394

  2. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2016 被引用: 818

  3. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric Meffre, Thomas A. Fleisher, Steven M. Holland, Michael J. Lenardo, Stuart G. Tangye, Gülbû Uzel - Science 2014 被引用: 855

  4. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Edward W. Cowen, John J. DiGiovanna, Massimo Gadina, Andrew Lipton, Colleen Hadigan, Steven M. Holland, Joseph R. Fontana, Ahmad S. Alawad, Rebecca J. Brown, Kristina I. Rother, Theo Heller, Kristina M. Brooks, Parag Kumar, Stephen R. Brooks, Meryl Waldman, Harsharan K. Singh, Volker Nickeleit, Maria Silk, Apurva Prakash, Jonathan Janes, Seza Özen, Paul Wakim, Paul Brogan, William L. Macias, Raphaela Goldbach‐Mansky - Journal of Clinical Investigation 2018 被引用: 521

  5. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John B. Wong, Kimberly Workowski - Clinical Infectious Diseases 2018 被引用: 726

  6. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George H. Caughey, Theo Heller, Dean D. Metcalfe, Leslie G. Biesecker, Lawrence B. Schwartz, Joshua D. Milner - Nature Genetics 2016 被引用: 393

  7. Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heidi H. Kong, Sophie Hambleton, Fabio Candotti, Martha Quezado, Katherine R. Calvo, Hawwa Alao, Beverly Barham, Anne Jones, James F. Meschia, Bradford B. Worrall, Scott E. Kasner, Stephen S. Rich, Raphaela Goldbach‐Mansky, Mario Abinun, Elizabeth Chalom, Alisa Gotte, Marilynn Punaro, Virginia Pascual, James Verbsky, Troy R. Torgerson, Nora G. Singer, Timothy R. Gershon, Seza Özen, Ömer Karadağ, Thomas A. Fleisher, Elaine F. Remmers, Shawn M. Burgess, Susan Moir, Massimo Gadina, Raman Sood, Michael S. Hershfield, Manfred Boehm, Daniel L. Kastner, Ivona Aksentijevich - New England Journal of Medicine 2014 被引用: 893

  8. Common Severe Infections in Chronic Granulomatous Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2014 被引用: 422

  9. The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leslie Castelo-Soccio, Ben Colton, Blake M. Warner, David E Kleiner, Martha M Quezado, Jeremy L. Davis, Kevin P Fennelly, Kenneth N. Olivier, Sergio D Rosenzweig, Anthony F. Suffredini, Mark S Anderson, Marc Swidergall, Carole Guillonneau, Luigi D Notarangelo, Raphaela Goldbach‐Mansky, Olaf Neth, Maria Teresa Monserrat-Garcia, Justo Valverde-Fernandez, Jose Manuel Lucena, Ana Lucia Gomez-Gila, Angela Garcia Rojas, Mikko Seppänen, Jouko Lohi, Matti Hero, Saila Laakso, Paula Klemetti, Vanja Lundberg, Olov Ekwall, Peter Olbrich, Karen K. Winer, Behdad Afzali, Niki M. Moutsopoulos, Steven M. Holland, Theo Heller, Stefania Pittaluga, Michail S. Lionakis - New England Journal of Medicine 2024 被引用: 77

  10. Danazol Treatment for Telomere Diseases

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 402

  11. Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2010 被引用: 560

  12. Longitudinal multi-omics analyses of the gut–liver axis reveals metabolic dysregulation in hepatitis C infection and cirrhosis

    著者: , , , , , , , , , , , , , , , , , , , , - Nature Microbiology 2022 被引用: 47

  13. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Katherine R. Calvo, Jennifer Adjemian, Morgan Similuk, David M. Lang, Kelly D. Stone, Gülbû Uzel, Jeffrey B. Kopp, Rachel Bishop, Steven M. Holland, Kenneth N. Olivier, Thomas A. Fleisher, Theo Heller, Karen K. Winer, Michail S. Lionakis - JCI Insight 2016 被引用: 304

  14. Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laurie Brenchley, Eileen Pelayo, Wadih M. Zein, Nida Sen, Alexander H. Yang, Gary L. Farley, David A. Sweetser, Lauren C. Briere, Janine Yang, Fabiano de Oliveira Poswar, Ida Vanessa Döederlein Schwartz, Tamires Silva Alves, Perrine Dusser, Isabelle Koné‐Paut, Isabelle Touitou, Salah Mohamed Titah, P. Martin van Hagen, Rogier T. A. van Wijck, Peter J. van der Spek, Hiromi YANO, Andreas Benneche, Ellen M. Apalset, Ragnhild Wivestad Jansson, Rachel R Caspi, Douglas B. Kuhns, Massimo Gadina, Hidetoshi Takada, Hiroaki Ida, Ryuta Nishikomori, Elena Verrecchia, Eugenio Sangiorgi, Raffaele Manna, Brian P. Brooks, Lucia Sobrin, Robert B. Hufnagel, David B. Beck, Feng Shao, Amanda K. Ombrello, Ivona Aksentijevich, Daniel L. Kastner, Maria T. Acosta, Margaret Adam, David R. Adams, Justin Alvey, Laura Amendola, Ashley Andrews, Euan A. Ashley, Mahshid S. Azamian, Carlos A. Bacino, Guney Bademci, Ashok Balasubramanyam, Dustin Baldridge, Jim Bale, Michael Bamshad, Deborah Barbouth, Pinar Bayrak-Toydemir, Anita Beck, Alan H. Beggs, Edward Behrens, Gill Bejerano, Jimmy Bennet, Beverly Berg-Rood, Jonathan A. Bernstein, Gerard T. Berry, Anna Bican, Stephanie Bivona, Elizabeth Blue, John Bohnsack, Devon Bonner, Lorenzo Botto ほか 233 名 - Annals of the Rheumatic Diseases 2022 被引用: 70

  15. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study

    著者: , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 58

  16. Liver-Resident Bystander CD8+ T Cells Contribute to Liver Disease Pathogenesis in Chronic Hepatitis D Virus Infection

    著者: , , , , , , , , , - Gastroenterology 2021 被引用: 53

  17. Natural history study of patients with familial platelet disorder with associated myeloid malignancy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raul C. Braylan, Paul Liu - Blood 2023 被引用: 43

  18. Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nehal N. Mehta, Mariana J. Kaplan - Annals of the Rheumatic Diseases 2022 被引用: 25

  19. Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George Chong, Aurélie Fabre, Sylviane Olschwang, Geoffrey J. Faulkner, Evangelos Bellos, Lachlan Coin, Kevin P. Rioux, Oliver F. Bathe, Xiaogang Wen, Hilary C. Martin, Deborah W. Neklason, Sean Davis, Robert L. Walker, Kathleen A. Calzone, Itzhak Avital, Theo Heller, Christopher Koh, Marbin Pineda, Udo Rudloff, Martha Quezado, Pavel N. Pichurin, Peter J. Hulick, Scott M. Weissman, Anna Newlin, Wendy S. Rubinstein, Jone E. Sampson, Kelly Hamman, David Goldgar, Nicola Poplawski, Kerry Phillips, Lyn Schofield, Jacqueline Armstrong, Cathy Kiraly‐Borri, Graeme Suthers, David G. Huntsman, William D. Foulkes, Fátima Carneiro, Noralane M. Lindor, Stacey L. Edwards, Juliet D. French, Nicola Waddell, Paul S. Meltzer, Daniel L. Worthley, Kasmintan A. Schrader, Georgia Chenevix‐Trench - The American Journal of Human Genetics 2016 被引用: 265

  20. Simtuzumab treatment of advanced liver fibrosis in HIV and HCV‐infected adults: results of a 6‐month open‐label safety trial

    著者: , , , , , , , , , , , , , , , , , , , , , - Liver International 2016 被引用: 98

  21. A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis

    著者: , , , , , , , , , , , , , , , - Hepatology 2021 被引用: 77

  22. Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection

    著者: , , , , , , , , , , - Gastroenterology 2011 被引用: 310

  23. Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2015 被引用: 263

  24. Pathogenesis of and New Therapies for Hepatitis D

    著者: , , - Gastroenterology 2018 被引用: 110